XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Short term debt

Annual short term debt:

$21.18M+$17.69M(+506.07%)
December 31, 2024

Summary

  • As of today (September 16, 2025), XERS annual short term debt is $21.18 million, with the most recent change of +$17.69 million (+506.07%) on December 31, 2024.
  • During the last 3 years, XERS annual short term debt has risen by +$21.18 million (+100.00%).
  • XERS annual short term debt is now at all-time high.

Performance

XERS Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSbalance sheet metrics

quarterly short term debt:

$6.16M-$11.92M(-65.94%)
June 30, 2025

Summary

  • As of today (September 16, 2025), XERS quarterly short term debt is $6.16 million, with the most recent change of -$11.92 million (-65.94%) on June 30, 2025.
  • Over the past year, XERS quarterly short term debt has increased by +$849.00 thousand (+16.00%).
  • XERS quarterly short term debt is now -99.74% below its all-time high of $2.39 billion, reached on December 31, 2017.

Performance

XERS quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

XERS Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+506.1%+16.0%
3 y3 years+100.0%+100.0%
5 y5 years-+100.0%

XERS Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high>+9999.0%-70.9%>+9999.0%
5 y5-yearat high>+9999.0%-70.9%>+9999.0%
alltimeall timeat high>+9999.0%-99.7%>+9999.0%

XERS Short term debt History

DateAnnualQuarterly
Jun 2025
-
$6.16M(-65.9%)
Mar 2025
-
$18.08M(-14.7%)
Dec 2024
$21.18M(+506.1%)
$21.18M(+0.4%)
Sep 2024
-
$21.10M(+297.6%)
Jun 2024
-
$5.31M(+14.8%)
Mar 2024
-
$4.62M(+32.3%)
Dec 2023
$3.50M(+121.2%)
$3.50M(+47.7%)
Sep 2023
-
$2.37M(+22.3%)
Jun 2023
-
$1.94M(+33.6%)
Mar 2023
-
$1.45M(-8.4%)
Dec 2022
$1.58M(>+9900.0%)
$1.58M(>+9900.0%)
Sep 2022
-
$0.00(0.0%)
Jun 2022
-
$0.00(0.0%)
Mar 2022
-
$0.00(0.0%)
Dec 2021
$0.00
$0.00(0.0%)
DateAnnualQuarterly
Sep 2021
-
$0.00(0.0%)
Jun 2021
-
$0.00(0.0%)
Mar 2021
-
$0.00(0.0%)
Dec 2020
-
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
Mar 2020
-
$0.00(0.0%)
Dec 2019
-
$0.00(0.0%)
Sep 2019
-
$0.00(-100.0%)
Jun 2019
-
$3.00M(>+9900.0%)
Mar 2019
-
$0.00(0.0%)
Dec 2018
-
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
Mar 2018
-
$0.00(-100.0%)
Dec 2017
-
$2.39B

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual short term debt?
  • What is the all time high annual short term debt for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual short term debt year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly short term debt?
  • What is the all time high quarterly short term debt for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly short term debt year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual short term debt?

The current annual short term debt of XERS is $21.18M

What is the all time high annual short term debt for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual short term debt is $21.18M

What is Xeris Biopharma Holdings, Inc. annual short term debt year-on-year change?

Over the past year, XERS annual short term debt has changed by +$17.69M (+506.07%)

What is Xeris Biopharma Holdings, Inc. quarterly short term debt?

The current quarterly short term debt of XERS is $6.16M

What is the all time high quarterly short term debt for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly short term debt is $2.39B

What is Xeris Biopharma Holdings, Inc. quarterly short term debt year-on-year change?

Over the past year, XERS quarterly short term debt has changed by +$849.00K (+16.00%)
On this page